Financial Security Advisor’s SpringWorks Therapeutics SWTX Stock Holding History

Financial Security Advisor’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,755	Closed	-$223K	–	146
2025 Q2	$223K	Hold	4,755	–	–	0.05%	116
2025 Q1	$210K	Buy	+4,755	New	+$219K	0.05%	116
2024 Q2	–	Sell	-5,000	Closed	-$246K	–	120
2024 Q1	$246K	Buy	+5,000	New	+$231K	0.09%	90
2023 Q4	–	Sell	-31,758	Closed	-$734K	–	109
2023 Q3	$734K	Buy	+31,758	New	+$868K	0.34%	43

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Financial Security Advisor's SWTX Position: Q3 2025 in Review

Financial Security Advisor sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,755 shares — an estimated $223K sold.

Financial Security Advisor first reported a position in SWTX in Q3 2023 and held it in 4 quarters. The position peaked at $734K in Q3 2023. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Financial Security Advisor reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Financial Security Advisor sold 4,755 SpringWorks Therapeutics shares in Q3 2025, an estimated $223K.
Financial Security Advisor first reported a position in SpringWorks Therapeutics in Q3 2023 and held it in 4 quarters.
Financial Security Advisor's SpringWorks Therapeutics position peaked at $734K in Q3 2023.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Financial Security Advisor's 13F filing for Q3 2025, filed 3 Nov 2025.